SCHEMBL3655682

SCHEMBL3655682

Cc1sccc1NS(=O)(=O)c1ccc(C(C)(C)C)cc1

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 8/20 0.55
UQCRB P14927 2/20 0.55
CA1 P00915 2/20 0.54
CA2 P00918 2/20 0.54
ALDH1A1 P00352 5/20 0.51
MEN1 O00255 2/20 0.50
MAPT P10636 2/20 0.50
KMT2A Q03164 2/20 0.50
PSD A5PKW4 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C19 P33261 1/20 0.50
GLO1 Q04760 1/20 0.48
KDM4E B2RXH2 2/20 0.48
LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2747439 0.80 ACLY (0.60) HSD17B2UQCRBCA1CA2ALDH1A1
SCHEMBL2747919 0.78 LMNA (0.74) HSD17B2UQCRBALDH1A1MEN1MAPT
SCHEMBL7587850 0.77 HSD17B2 (0.79) HSD17B2UQCRBCA1CA2ALDH1A1
SCHEMBL812679 0.73 ALDH1A1 (0.83) UQCRBCA1CA2ALDH1A1MEN1
SCHEMBL15248886 0.73 HSD17B2 (0.74) HSD17B2UQCRBCA1CA2ALDH1A1
SCHEMBL13476997 0.73 SCN9A (0.36) HSD17B2MEN1KMT2A
SCHEMBL4550967 0.72 MAPT (0.61) ALDH1A1MEN1MAPTKMT2ALMNA
SCHEMBL1040954 0.71 ALDH1A1 (0.73) HSD17B2UQCRBCA1CA2ALDH1A1
SCHEMBL13433558 0.71 ALDH1A1 (0.73) HSD17B2UQCRBCA1CA2ALDH1A1
SCHEMBL13852837 0.71 HSD17B2 (0.68) HSD17B2UQCRBCA1CA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2220065-A2 MODULATORS OF CCR9 RECEPTOR AND METHODS OF USE THEREOF ENCYSIVE PHARMACEUTICALS, INC. (US) 2010-08-25 EP disclosed
WO-2009017719-A2 MODULATORS OF CCR9 RECEPTOR AND METHODS OF USE THEREOF ENCYSIVE PHARMACEUTICALS, INC. (US) 2009-02-05 WO disclosed